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Abstract
The fidelity of protein synthesis depends on the capacity of amino-
acyl-tRNA synthetases (AARSs) to couple only cognate amino acid-
tRNA pairs. If amino acid selectivity is compromised, fidelity can be
ensured by an inherent AARS editing activity that hydrolyses
mischarged tRNAs. Here, we show that the editing activity of
Escherichia coli leucyl-tRNA synthetase (EcLeuRS) is not required to
prevent incorrect isoleucine incorporation. Rather, as shown by
kinetic, structural and in vivo approaches, the prime biological
function of LeuRS editing is to prevent mis-incorporation of the
non-standard amino acid norvaline. This conclusion follows from a
reassessment of the discriminatory power of LeuRS against
isoleucine and the demonstration that a LeuRS editing-deficient
E. coli strain grows normally in high concentrations of isoleucine
but not under oxygen deprivation conditions when norvaline
accumulates to substantial levels. Thus, AARS-based translational
quality control is a key feature for bacterial adaptive response to
oxygen deprivation. The non-essential role for editing under normal
bacterial growth has important implications for the development of
resistance to antimicrobial agents targeting the LeuRS editing site.
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Introduction
Aminoacyl-tRNA synthetases (AARSs) define the genetic code
through the covalent pairing of amino acids with their cognate tRNAs
to provide the activated aminoacyl moiety for ribosomal protein
synthesis. Aminoacylation is a two-step reaction localized within the
synthetic active site of the AARS catalytic domain (reviewed in First,
2005; Perona & Gruic-Sovulj, 2013). Firstly, ATP-dependent
amino acid activation yields an aminoacyl-adenylate intermediate
(AA-AMP) that remains non-covalently bound in the synthetic site.
In the second step, either the 20- or 30-OH group of the terminal
adenosine of the tRNA attacks the carbonyl carbon of AA-AMP,
leading to transfer of the aminoacyl moiety onto the tRNA (Fig 1).
Based on the differences in the architecture and topology of the cata-
lytic domains, AARSs are divided into two classes, class I consisting
of 11 members and class II of 13 members (Cusack, 1997; de Pouplana
& Schimmel, 2001; Eriani et al, 1990; Perona & Hadd, 2012).
Many AARSs are incapable of distinguishing between cognate
and near-cognate amino acids with high specificity in the synthetic
reaction alone. These enzymes instead use intrinsic hydrolytic
proof-reading to minimize the error to the level tolerated in protein
synthesis (1 in 103–104). Editing may operate through the several
pathways localized in the two distinct active sites: the synthetic site
at the catalytic core and the editing site in a distinct editing domain
(Fig 1; reviewed in Perona & Gruic-Sovulj, 2013). Hydrolysis of
non-cognate AA-AMP (pre-transfer editing), both tRNA-independent
and tRNA-dependent, takes place within the confines of the
synthetic site (Fig 1, paths 1 and 3) (Cvetesic et al, 2012; Dulic et al,
2010; Gruic-Sovulj et al, 2007; Minajigi & Francklyn, 2010; Splan
et al, 2008). The relevance of pre-transfer editing is defined by the
kinetic partitioning of AA-AMP within the synthetic site (Dulic et al,
2010; Minajigi & Francklyn, 2010). If the rate of aminoacyl transfer
to the tRNA is significantly faster than the rate of AA-AMP hydro-
lysis, the non-cognate amino acid may evade pre-transfer editing.
Misacylated tRNA is then cleared by post-transfer editing at the
specialized editing domain. Non-cognate amino acid is delivered to
the distant hydrolytic site by translocation of the 30-end of the
misacylated tRNA.
Leucyl-tRNA synthetase (LeuRS) provides a cellular pool of Leu-
tRNALeu, thus allowing the programmed insertion of leucine into
proteins. Besides leucine, Escherichia coli LeuRS (EcLeuRS) activates
structurally similar but non-cognate isoleucine, norvaline, norleu-
cine, and methionine with a frequency that generally exceeds the
tolerated translational error (Chen et al, 2000; Cvetesic et al, 2012;
Martinis & Fox, 1997; Tang & Tirrell, 2002). To clear errors of
aminoacylation, EcLeuRS exhibits efficient post-transfer editing
(Cvetesic et al, 2012; Lincecum et al, 2003; Mursinna et al, 2004)
localized at a discrete 189 amino acids long peptide, called
connective peptide 1 (CP1) that is inserted into the Rossmann fold
of the canonical class I AARS catalytic domain (Cusack et al, 2000;
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Palencia et al, 2012). This feature is shared with homologous isoleu-
cyl- and valyl-tRNA synthetase (IleRS and ValRS) (Dulic et al, 2010;
Fukai et al, 2000; Silvian et al, 1999). Isoleucine is generally
thought to be a significant threat to the accuracy of leucylation
(Boniecki et al, 2008; Lincecum et al, 2003; Lue & Kelley, 2005;
Martinis & Fox, 1997; Mursinna et al, 2004). However, some doubt
about the promiscuity of LeuRS towards isoleucine comes from the
observation that reported discrimination factors for isoleucine
(defined as (kcat/Km)Leu/(kcat/Km)Ile) substantially differ [from 630
(Chen et al, 2000) to 5,400 (Tang & Tirrell, 2002)]. So far, the signif-
icance of isoleucine editing has not been substantiated by detailed
kinetic analyses of the synthetic and editing isoleucine pathways.
Norvaline, a side product of the leucine biosynthetic pathway
(Umbarger, 1978), may pose a significant threat to fidelity of protein
synthesis under limited-oxygen growth conditions (Soini et al,
2008) where it accumulates to a concentration capable of potentially
jeopardizing the accuracy of Leu-tRNALeu synthesis by E. coli. Our
in-depth kinetic analysis established that norvaline at millimolar
amounts is rapidly activated and transferred to tRNALeu by EcLeuRS.
Yet, availability of Nva-tRNALeu for protein synthesis is effectually
prevented by rapid hydrolysis of the misacylated tRNA at the LeuRS
CP1 editing site (Cvetesic et al, 2012). Single-turnover kinetic analy-
sis revealed the LeuRS CP1 editing site exhibits enhanced substrate
specificity for norvaline. This might indicate that the LeuRS editing
has been evolutionary optimized to eliminate non-proteinogenic
norvaline rather than isoleucine.
To explore whether isoleucine discrimination by LeuRS differs
from the mechanisms that assure specificity against norvaline, we
performed an extensive kinetic and thermodynamic analyses of
LeuRS synthetic and editing pathways using isoleucine as the non-
cognate substrate. Unexpectedly, we find that LeuRS discriminates
against isoleucine at the activation step with 104-fold specificity that
arises from weak ground state binding and decreased rate of the
chemical step. Our data show that the prevailing opinion that LeuRS
frequently misactivates isoleucine is mistaken because it is based on
measurements with impure isoleucine samples that contain traces of
leucine. The crystal structure of the ternary complex formed by
EcLeuRS, tRNALeu, and the non-cognate isoleucyl-adenylate
analogue (Ile-AMS) unveils a novel mechanism of ground state
discrimination, whereby the active site geometry ensures selectivity
against the most abundant amino acid conformer. The growth of an
E. coli strain deprived of LeuRS post-transfer editing displays a high
tolerance towards a surplus of isoleucine, but not norvaline, in the
media. We thus propose that the prime biological importance of the
editing domain of LeuRS is to exclude the non-canonical norvaline
from protein synthesis and thus preserve the canonical genetic code
under norvaline-rich (micro-aerobic) growth conditions. Our data
show that AARS editing is an essential part of the cellular mecha-
nisms that ensure bacterial adaptability to changing environment.
Results
Isoleucine is effectively eliminated in the synthetic reaction
of LeuRS
Characterization of the several commercial isoleucine lots, by kinet-
ics and NMR spectroscopy, revealed contamination with leucine in
the 0.0019–0.38% range (see Supplementary Materials and Methods,
and Supplementary Fig S1 and S2). Although the percentage of
leucine appears low, two major kinetic artifacts nonetheless
emerged as a consequence of leucine impurities in the isoleucine
samples: (i) inhibition of LeuRS editing at high concentrations of
isoleucine (Supplementary Fig S3) and (ii) substantially lower
discrimination factor for isoleucine at the activation step (100 versus
8,000 for the samples with 0.38% and 0.0019% of leucine, respec-
tively; Supplementary Table S1). The latter may explain the
observed inconsistency in the published discrimination factors
(from 630 to 5,400) for activation of isoleucine by EcLeuRS (Boniecki
et al, 2008; Chen et al, 2000; Lue & Kelley, 2005; Tang & Tirrell,
2002). Our data re-emphasize the difficulties associated with the
presence of trace levels of cognate amino acid in a non-cognate
amino acid sample (Fersht & Dingwall, 1979b) and thus highlight
the importance of a careful analysis of the amino acid substrates.
Figure 1. Schematic presentation of editing pathways.
Pre-transfer editing can occur through enhanced dissociation of non-cognate aminoacyl-adenylate (2) or its enzymatic hydrolysis (1, 3), which may be tRNA-
independent (1) or tRNA-dependent (3). After transfer, mischarged tRNA can be deacylated through post-transfer editing (4). The colors in the scheme match the color of
the domain where the reaction occurs (yellow, catalytic domain; cyan, editing domain; see Fig 4).
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The problem was addressed by further purification of the
commercial isoleucine samples prior to their use in kinetic assays
(see Supplementary Materials and Methods). Ultra-pure isoleucine
(around 0.00035% of leucine) was produced and used for determi-
nation of the kinetic parameters for activation of isoleucine by
EcLeuRS. Remarkably, we observed that LeuRS discriminates
robustly against isoleucine in the activation step, with a discrimina-
tion factor as high as 31,000 (Table 1). Thus, utilization of ultra-
pure isoleucine revealed that LeuRS discriminates substantially
better against isoleucine than was expected based on data with non-
purified isoleucine samples (Supplementary Table S1 and Boniecki
et al, 2008; Chen et al, 2000; Lue & Kelley, 2005). It thus appears
that isoleucine will be mistakenly activated by LeuRS only with
frequency 1 in 31,000: significantly lower than the observed error in
protein synthesis (1 in 3,300, Loftfield & Vanderjagt, 1972). This
suggests that editing of isoleucine is not essential and thus argues
against the view that editing of isoleucine by LeuRS is a major
defense against mistranslation of leucine codons as isoleucine in
E. coli (Boniecki et al, 2008; Lue & Kelley, 2005).
Comparison of isoleucine and norvaline kinetic parameters in
amino acid activation by LeuRS (Table 1) shows that both non-
cognate substrates are discriminated at the level of ground state
binding with the more prominent effect in the case of isoleucine. In
sharp contrast, isoleucine, but not norvaline, is also significantly
discriminated at the catalytic step (kcat is decreased 55-fold). This is
unusual because neither ValRS nor IleRS discriminates against non-
cognate threonine and valine, respectively, at the level of kcat in acti-
vation (Dulic et al, 2010; Fersht, 1977; Fersht & Kaethner, 1976).
We further tested activation of the substantially smaller non-cognate
a-aminobutyric acid (Aba) by LeuRS and find that kcat is not highly
compromised. The major effect (1,700 fold) was again observed at
the level of Km (Table 1). It thus appears that considerably slower
activation is a distinctive feature of isoleucine rejection by LeuRS.
Next, we explored LeuRS discrimination against isoleucine in
aminoacylation. Although aminoacyl transfer is generally taken as
non-discriminative (Cvetesic et al, 2012; Dulic et al, 2010; Lin et al,
1984; Minajigi & Francklyn, 2010), it is known that tRNA may
modulate the activation step (Bovee et al, 2003; Dibbelt et al, 1980;
Gruic-Sovulj et al, 2002; Guth et al, 2005; Minajigi & Francklyn,
2010). The two-step aminoacyl-tRNALeu formation was followed
under single-turnover conditions using 4-fold excess of the enzyme
over tRNA (Fig 2A and B). Hydrolysis of Ile-tRNALeu was disabled
by use of the LeuRS mutant (D345A LeuRS) inactivated in the CP1
editing site (Cvetesic et al, 2012; Lincecum et al, 2003). Thus,
D345A LeuRS pre-incubated with ATP, and a limiting amount of
[32P]-tRNA under the saturating conditions was mixed with various
concentrations of amino acid (isoleucine or leucine) using a rapid
chemical quench instrument. Several modes of mixing were tested,
Table 1. Steady-state parameters for amino acid activation by wild-type (WT) EcLeuRSa
AA AA structure
Km (AA) kcat kcat/Km
Discrimination factorbmM s1 mM1s1
WT LeuRS
Leuc O
NH2
CH3
CH3
OH
0.05  0.01 66  2 1,320
Nvac O
NH2
OH
CH3
4.9  0.4 56  1 11.4 116
Abad O
NH2
OHCH3
85  9 20  1 0.24 5,500
Ilee,g O
NH2
CH3
CH3 OH
26  7 1.1  0.1 0.042 31,429
M40G LeuRS
Leuf O
NH2
CH3
CH3
OH
0.34  0.03 6.9  0.2 20
Nvaf O
NH2
OH
CH3
17  3 4.2  0.3 0.247 81
Ilee,g O
NH2
CH3
CH3 OH
10  2 1.14  0.06 0.114 175
The values represent the best fit value  s.e.m. of at least two independent experiments.
aMeasured by ATP-PPi exchange assay.
bDiscrimination factor is defined as (kcat/Km)cognate/(kcat/Km)non-cognate.
cParameters reported in (Cvetesic et al, 2012).
WT or M40G LeuRS were used at d10 nM, e150 nM, or f50 nM concentration, and Leu, Nva, and Ile concentrations were varied over the range 0.1–10 times
the Km.
gIsoleucine preparation used to determine activation parameters was purified as described in the Supplementary Materials and Methods.
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and no difference in reaction kinetics was observed. Time-course of
AA-[32P]-tRNA formation fit best to a single exponential equation at
each concentration of the amino acid (either isoleucine or leucine).
The curves were carefully inspected for a lag in product formation
at the moderate amino acid concentrations, and no lag was
observed (Fig 2C), indicating that the binding step is a rapid equilib-
rium. The observed first-order rate constants (kobs) extracted from
the exponential curves were plotted versus amino acid concentra-
tion, and in each case, the resulting curve was fit to a hyperbola
from which the apparent binding constant (Kd) and the maximal
composite rate of the activation and transfer chemical steps (kchem)
were directly obtained (Fig 2A and B). Hyperbolic dependency is
consistent with a minimal (simplified) reaction scheme (Figure 3),
whereby the initial binding of amino acid is a rapid equilibrium
reaction, and the subsequent steps in aminoacyl-tRNA formation,
amino acid activation and/or transfer, define the maximal single-
turnover rate (Johnson, 1992).
The observed 500-fold difference in Kd (Kd (Leu) = 41 lM and Kd
(Ile) = 26 mM) is consistent with the 500-fold observed difference
in Km in the ATP-PPi exchange reaction. A significant portion of the
selectivity also arises at the chemical steps of aminoacyl-tRNA
formation (kchem(Ile) = 1.14 s
1 and kchem(Leu) = 19 s
1). Discrim-
ination against isoleucine in the overall two-step aminoacylation
([kchem/Kd]Leu/[kchem/Kd]Ile = 11,000) is thus consistent with
discrimination exerted in the first step, showing that tRNALeu does
not modulate LeuRS specificity.
Idiosyncratic discrimination against isoleucine at the aminoacyl
transfer step
To investigate whether LeuRS also discriminates against isoleucine at
the transfer step, the LeuRS:AA-AMP complex preformed in situ was
mixed with a limiting amount of [32P]-tRNA and the AA-[32P]-tRNA
formation was followed in time. Interestingly, a 50-fold slower transfer
of isoleucine (1.3 s1; Fig 2D) as compared with leucine (58 s1;
Cvetesic et al, 2012) was observed. Several controls were undertaken
that proved that the transfer step, not slow activation, has been
indeed followed (see Materials and Methods). Finally, LeuRS:Ile-AMP
was isolated by size-exclusion chromatography prior to use in the
A B
C D
Figure 2. Kinetic analyses of leucine or isoleucine-dependent synthetic pathway.
A Plot of single-turnover leucylation rate constant by D345A LeuRS versus leucine concentration.
B Plot of single-turnover isoleucylation rate constant by D345A LeuRS vs. isoleucine concentration.
C Representative isoleucylation time-courses by D345A LeuRS performed at 2 (●), 4 (○), 6 (♦) or 10 (◊) mM isoleucine concentration.
D Single-turnover isoleucine transfer by D345A LeuRS. Errors bars correspond to the s.e.m. from three independent experiments.
Figure 3. Aminoacetylation reaction mechanism.
A minimal reaction scheme for the mechanism whereby the initial binding of
amino acid is in rapid equilibrium and the subsequent reaction steps define the
maximal single-turnover rate of aminoacylation.
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single-turnover transfer assay. The derived kobs was 0.5 s
1,
confirming unequivocally the slow transfer of the isoleucyl moiety. To
provide further insight into the specificity of the LeuRS transfer step,
transfer of Aba to tRNALeu was also followed. Interestingly, Aba is
rapidly transferred (26  3 s1) comparable with the reported rapid
transfer of norvaline moiety (Cvetesic et al, 2012). It thus appears that
slow transfer is an idiosyncratic feature of isoleucine as a substrate of
LeuRS. Apparently, the aminoacyl transfer in some cases can embody
specificity against amino acid. It has been recently shown that
Mycoplasma mobile PheRS also transfers tyrosine 5-fold slower than
the cognate phenylalanine to the tRNAPhe (Yadavalli & Ibba, 2013).
Structural basis of isoleucine discrimination by LeuRS
To understand the structural basis for the high discrimination against
isoleucine by LeuRS, we determined the crystal structure of EcLeuRS
bound to the cognate tRNALeu and a non-hydrolysable analogue
of isoleucyl-adenylate (Ile-AMS) at 2.4 A˚ resolution (Table 2). The
complex adopts an aminoacylation-like conformation where the
30 end of the tRNA and Ile-AMS are bound in the kinetically
productive position for the transfer of isoleucyl moiety to the tRNA
(Fig 4A).
At a protein level, there are no major structural differences at the
synthetic site when the cognate (Leu-AMS) or non-cognate (Ile-AMS)
AA-AMP analogues are bound. Some minor changes (about 0.8 A˚
movements) are observed in the positions of the terminal ribose of
the tRNA and the residue His537, but their significance is not clear.
Interestingly, in spite of the slight movement of the 20-OH of Ade76,
its relative distance to the carbonyl carbon atom of isoleucine
remains compatible with the transfer step (2.8 A˚) (Fig 4B). This is
intriguing as isoleucyl transfer to the tRNA proceeds with 50-fold
decreased rate as compared with the leucyl transfer (see Discussion).
Discrimination against isoleucine is ensured by the lack of van der
Waals contacts between its b-branched side chain and the synthetic
site pocket. Indeed, inspection of the LeuRS:Leu-AMS structure
bound to tRNA revealed that both d-C atoms of the leucine side chain
are well accommodated within the hydrophobic pocket which
contributes favorably to the binding energy. The striking feature of
the LeuRS:tRNALeu:Ile-AMS ternary complex is the particular confor-
mation of the bound isoleucine substrate, which appears to be
imposed by the geometry of the synthetic site. L-isoleucine presents
four different conformations in solution: trans, with a dihedral angle
X2 (formed by carbons a, b, c and d1) of about 170 degrees, gauche –
(X2 ~ 300 degrees), gauche + (X2 ~ 66 degrees), and gauche 100
(X2 ~ 100 degrees). The trans conformation is the most favorable
energetically and hence the most abundant in solution (~ 81%),
followed by gauche – (~15%), while the other two conformations
account for less than 4% (Hansen et al, 2010; Lovell et al, 2000).
Remarkably, our structure reveals that the conformation of isoleu-
cine bound in the synthetic site corresponds to a ‘gauche – like’
conformation (X2 = 243 degrees) and that binding of the trans
conformation is sterically prevented by the geometry of the LeuRS
synthetic site, in particular by Met40 (Fig 4B and C). In contrast,
isoleucine adopts the more favored trans conformation when bound
to the cognate IleRS synthetic site (Nakama et al, 2001). This
suggests that isoleucine recognition by LeuRS exhibits a novel mech-
anism of discrimination at the ground state level that results in a
very weak amino acid binding affinity. To provide more quantitative
insight, binding of isoleucine and leucine to EcLeuRS was followed
using isothermal titration calorimetry (ITC). Thermodynamic analy-
sis confirmed very weak binding of isoleucine (Kd > 10 mM,
Fig 5A), consistent with Km (26 mM) and kinetic Kd (26 mM)
obtained in the activation and two-step aminoacylation reactions,
respectively (Table 1 and Fig 2). Indeed, LeuRS displays three orders
of magnitude higher affinity for cognate leucine (Kd = 60 lM,
Fig 5B) than for isoleucine. The Kd values extracted from ITC
measurements of Ile-AMS or Leu-AMS binding to LeuRS are substan-
tially lower compared with the values for the free amino acids,
confirming the significant contribution of the AMP moiety to the
Table 2. Data collection and refinement statistics
E. coli LeuRS:tRNALeu (UAA):IleAMS
Data collection
Space group C2
Cell dimensions
a, b, c (Å) 155.62, 67.58, 224.59
a, b, c (°) 90.00, 105.0, 90.00
Resolution (Å)a 46.5–2.5 (2.500–2.505)
Rsym 17.0 (68.5)
I/rI 7.0 (1.8)
Completeness (%) 97.1 (98.7)
Redundancy 3.17 (3.18)
Refinement
Resolution (Å) 2.5
No. reflections work/free 72414/3828
Rwork/Rfree 0.213/0.290
No. atoms
Protein 6907[A]b/6897[D]
tRNA 1756[B]/1692[E]
Ligand 124 (4 × IleAMS)
Mg2+ 1[B]/1[E]
Zn2+ 1[A]/1[D]
Water/other 306
B-factors
Protein 22.5[A]/74.4[D]
tRNA 30.13[B]/85.7[E]
Ligand 9.6[A1]c/28.7[A2]c
49.7[D1]/144.5[D2]
Mg2+ 25.2[B]/52.1[E]
Zn2+ 65.7[A]/100.4[D]
Water 19.8[Z]
R.M.S. deviations
Bond lengths (Å) 0.010
Bond angles (°) 1.502
aValues in parentheses are for highest-resolution shell.
bValues are for each molecule in the asymmetric unit with chain indicator
given in square brackets.
cNumber 1 denotes Ile-AMS ligands bound into the synthetic site, and
number 2 bound into the editing site.
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energetics of binding (~103), while retaining a significant difference
of affinity between the cognate and non-cognate AA-AMP analogues
(Fig 5C and D).
Most likely as a consequence of the high concentration of the
analogue used in crystallization, we observed a second Ile-AMS
molecule bound in the LeuRS CP1 editing site, which adopts a differ-
ent conformation compared with that bound in the synthetic site
(Fig 4D). The AMP moiety is also bound differently from the config-
uration observed in the complexes of the pre- and post-transfer
editing analogue of norvaline bound in the LeuRS CP1 editing site
(Lincecum et al, 2003). The reason for this is uncertain although it
is consistent with kinetic data showing that hydrolysis of Ile-AMP
does not occur within the CP1 editing site (see below). In contrast,
the aminoacyl part, including the amino and carbonyl groups, occu-
pies equivalent positions to those of norvaline in the CP1 editing site
(Fig 4E) (Lincecum et al, 2003). Interestingly, the conformation of
isoleucine at the editing site of LeuRS adopts the most stable confor-
mation in solution (trans). This indicates that interconversion of
isoleucine between different rotamers is not restricted by the struc-
ture of the adenylate and suggests that the ‘gauche – like’ conforma-
tion of isoleucine at the LeuRS synthetic site is selected from the
pool of different conformations existing in solution rather than due
to an artificial effect of the adenylate.
Methionine 40 is essential for LeuRS discrimination
against isoleucine
The LeuRS:tRNA:Ile-AMS structure indicates that the positions of
Met40 and possibly His533 impose steric constraints which are not
compatible with the binding of the trans conformation of isoleucine
(Fig 4B and C; Supplementary Fig S4). These residues are observed
invariably in the same conformation in various LeuRS structures.
We substituted Met40 with glycine and observed a 2.6-fold drop in
the Km for isoleucine in the activation step as compared to WT
(Table 1). This likely originates from loosening of the steric
constraints of the amino acid binding site. Surprisingly, however,
the M40G substitution induced a 200-fold loss in the capacity of the
synthetic site to discriminate against isoleucine (Table 1). The effect
originates predominantly from the cognate reaction; a 7-fold
increase in Km and 10-fold decrease in kcat yield 70-fold less efficient
leucine activation relative to the WT reaction. The structure of
LeuRS in complex with Leu-AMS and tRNA (Palencia et al, 2012)
A CB
ED
Figure 4. Structure of the E. coli LeuRS:tRNALeu complex with the non-cognate Ile-AMP analogue.
A Cartoon representation of the EcLeuRS:tRNALeu:Ile-AMS ternary complex showing the different domains colored as follows: yellow, catalytic domain; purple, ZN1
domain; cyan, editing domain; pink, leucine-specific domain; red, anticodon-binding domain; orange, C-terminal domain. The tRNALeu is represented in blue ribbon
with the last base Ade76 in sticks; the Ile-AMS analogues bound in the synthetic, and editing sites are shown as salmon and magenta sticks, respectively (carbon
atoms).
B Ade76 of tRNALeu and Ile-AMS bound in the synthetic site of E. coli LeuRS. The isoleucine part of Ile-AMS shows a gauche conformation. The residues involved in
isoleucine discrimination (see text) are represented as sticks.
C Same as (B) but with Ile-AMS from the IleRS:Ile-AMS complex (Pdb:1jzq) docked into the LeuRS synthetic site. Isoleucine adopts trans conformation in IleRS, which is
not compatible with the LeuRS synthetic site.
D Ile-AMS bound in the CP1-editing site of LeuRS, where isoleucine adopts trans conformation. Some of the key residues involved in post-transfer editing of non-
cognate amino acids and T252 (involved in leucine rejection) at the editing site of LeuRS are shown in sticks.
E Same as (D) but with norvaline post-transfer editing analogue (Nv2AA) docked into the editing site of LeuRS. The position of the aminoacyl part of isoleucine and
norvaline is equivalent.
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shows that the beta carbon of Met40 side chain is in van der Waals
contact with the beta carbon of the leucine side chain of Leu-AMS
and thus contributes to binding and productive positioning of
leucine for the chemical reaction. Thus, it appears that Met40 plays
a dual role in the synthetic site: (i) it enhances cognate leucylation
and (ii) it sterically discriminates against binding of the isoleucine
A B
C D
Figure 5. Isothermal titration calorimetry experiments showing the binding of cognate and non-cognate amino acids or AA-AMP analogues to E. coli LeuRS.
A–D EcLeuRS at 70 lM in the sample cell titrated by (A) isoleucine at 10 mM and (B) leucine at 2 mM, and titration of EcLeuRS at 20–25 lM by (C) Ile-AMS at 0.6 mM
and (D) Leu-AMS at 0.3 mM. The upper graphs show the raw data (in same scale to show the affinity differences), and the bottom graphs show the ligand
concentration dependence of the heat released upon binding after normalization. Kd values represent the average from at least two independent experiments (the
associated errors are about 5%). Inset panel show amplification of the binding profile.
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in the favorable trans conformation. It must be emphasized that
even in the M40G substituted LeuRS active site, isoleucine is kineti-
cally discriminated, which indicates that slow activation is primarily
not a consequence of the selected gauche – conformation. Interest-
ingly, the M40G substitution impairs kcat and Km values for norva-
line similarly as to leucine, leaving the discrimination factor in
amino acid activation unchanged.
Overall editing of isoleucine is limited by the rate of
Ile-tRNALeu formation
In the presence of isoleucine and absence of tRNA, EcLeuRS
accumulates AMP as a consequence of tRNA-independent editing
(Fig 6A). The observed rate is comparable to hydrolysis of
cognate Leu-AMP (kobs = 0.0100  0.0003 s1) and is 20-fold
slower than editing of norvaline (Cvetesic et al, 2012). Interest-
ingly, Ile-AMP accumulates above the enzyme concentration
(Fig 6B), which shows that a portion of Ile-AMP is released prior
to hydrolysis (Fig 1, pathway 2). In contrast, Leu-AMP does not
significantly dissociate into solution, presumably as a conse-
quence of its lower dissociation constant (Fig 5D). The distinction
between AA-[32P]-AMP and [32P]-AMP formation is possible
because of utilization of [a-32P]-ATP (Gruic-Sovulj et al, 2005).
The released AA-AMPs are prone to slow non-enzymatic hydro-
lysis, which usually does not substantially contribute to AMP
formation. To confirm this, non-enzymatic Ile-AMP hydrolysis
was followed by the cold-chase assay (Gruic-Sovulj et al, 2005).
The derived catalytic constant (kobs = (2.2  0.2) × 104 s1) was
45-fold smaller than the rate constant for AMP formation in the
presence of LeuRS (0.0100  0.0003 s1, Fig 6A), showing that
the observed editing is predominately an enzyme-based activity.
Inactivation of the CP1 editing site by D345A substitution did not
influence the rate of tRNA-independent editing of isoleucine
(kobs = 0.013 s
1), thus strongly indicating that pre-transfer edit-
ing does not reside in the CP1 editing site. This is consistent with
the recently established model, whereby AARS synthetic sites host
pre-transfer editing activity (Cvetesic et al, 2012; Dulic et al,
2010; Gruic-Sovulj et al, 2007; Minajigi & Francklyn, 2010; Splan
et al, 2008).
In the presence of tRNA, isoleucine is edited more rapidly
(Fig 6A) due to tRNA misacylation and subsequent post-transfer
editing at the LeuRS CP1 domain. To quantitatively describe tRNA-
dependent (overall) editing of isoleucine, kcat and Km kinetic
constants were extracted (Km = 31 mM and kcat = 0.104 s
1,
Supplementary Fig S3B). The high Km is consistent with the high Km
and Kd for isoleucine in activation and aminoacylation, respectively
(Table 1, Fig 2B). The kcat is significantly slower than the previ-
ously determined steady-state rate of Ile-tRNALeu deacylation
(kobs = 2 s
1; Cvetesic et al, 2012), indicating that kcat reflects Ile-
tRNALeu formation. To demonstrate this by an alternative approach,
activation of isoleucine was followed under the editing reaction
conditions. The catalytic constant (0.16 s1) was highly similar to
the aforementioned kcat, thus confirming that the overall editing of
isoleucine is limited by the rate of the synthetic pathway.
Isoleucine is edited only by the post-transfer LeuRS pathway
A significantly slower isoleucyl transfer step (1.3 s1) opens the
possibility that tRNA-dependent pre-transfer editing (if it exists in
the synthetic site of LeuRS) competes effectively with the transfer
step. To address this issue, we followed the initial steady-state
formation of AA-[32P]-tRNA and [32P]-AMP by the WT and deacyla-
tion-defective LeuRS enzymes in the parallel aminoacylation assays,
one relying on [32P]-tRNA another on [a-32P]-ATP (Cvetesic et al,
2012). Time-points were sampled to ensure conditions where the
tRNA is predominantly non-aminoacylated.
Enhanced AMP consumption during aminoacylation is diagnostic
of hydrolytic editing. Hence, an AMP/AA-tRNA ratio above 1 in the
presence of the post-transfer editing-deficient enzyme indicates the
existence of tRNA-dependent pre-transfer editing. Here, we show
that deacylation-defective LeuRS forms AMP and Ile-tRNALeu at
identical rates (Fig 7A), indicating that Ile-AMP formed in the
synthetic site is stoichiometrically used in Ile-tRNALeu synthesis. As
expected, WT LeuRS accumulates AMP substantially faster than Ile-
A B
Figure 6. Editing of isoleucine by WT LeuRS.
A AMP formation by 5 lM WT LeuRS in the absence of amino acid (×), in the presence of 50 mM Leu and absence of tRNALeu (○), and in the presence of 50 mM Ile and
presence (♦) or absence of 20 lM tRNALeu (●).
B AA-AMP formation by 5 lM WT LeuRS in the absence of tRNALeu and in the presence of 50 mM Leu (○), or 50 mM Ile (●). Errors bars correspond to the s.e.m. from
three independent experiments.
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tRNALeu because of active post-transfer editing (Fig 7B). Thus,
despite the inherently slower isoleucyl transfer step, tRNA-depen-
dent pre-transfer editing of isoleucine does not operate in the LeuRS
synthetic site. Instead, isoleucine editing relies almost exclusively
on the post-transfer pathway.
E. coli strain incapable of LeuRS editing tolerates substantial
concentration of isoleucine
To study in vivo requirements for editing, an E. coli MG1655 strain
that relies on the editing-defective D345A LeuRS was constructed by
replacement of the WT leuS gene with the gene for D345A LeuRS
using genetic recombination. Error-prone conditions were intro-
duced by supplementing the minimal media with either norvaline or
isoleucine. Inactivation of the LeuRS CP1 editing site did not induce
any growth defect in the absence of non-cognate amino acid supple-
ments, arguing against universal requirements for AARS editing
under non-error-prone conditions (Fig 8A). In sharp contrast, a
clear distinction between deacylation-defective and WT LeuRS
strains was observed in the presence of norvaline. Norvaline (in
concentrations as low as 1.5 mM) completely inhibits the growth of
the editing-defective strain, yet exhibits no impact on the growth of
the WT strain (Fig 8A). This is consistent with the recently demon-
strated high capacity of LeuRS to edit norvaline (Cvetesic et al,
2012). Replot of the growth rates versus norvaline concentrations
yields IC50 of about 0.1 mM (Fig 8B). Conversely, up to 20 mM
isoleucine did not induce a substantial effect on the growth of either
the deacylation-defective or the WT strain (Fig 8C). This is consis-
tent with some previous work (Karkhanis et al, 2007). An unspecific
inhibitory effect on both strains was observed with isoleucine above
30 mM (IC50 of 51 mM; Fig 8D), presumably as a consequence of
the artificially high amino acid concentration. We sought to confirm
the non-specificity of the effect by performing the same experiment
with leucine (Fig 8E and F). The same behavior was observed,
however at lower leucine concentration in agreement with its
known signaling role in E. coli (Newman & Lin, 1995). Since the
high surplus of isoleucine is well tolerated by the cells deprived of
LeuRS editing, it is unlikely the CP1 editing domain subsists to
ensure isoleucine editing.
LeuRS editing is crucial for E. coli viability under
micro-aerobic conditions
To explore whether LeuRS editing is a prerequisite for accurate
translation under growth conditions where norvaline accumulates,
we tested the viability of the WT and LeuRS editing-deficient strains
(D345A) under micro-aerobic conditions. Inactivation of editing had
no impact on the growth curves (Fig 9A), presumably because the
cultures still contained a substantial level of oxygen or did not accu-
mulate norvaline to a substantial concentration. However, as a
consequence of impaired oxygen transfer, the cells reached a
stationary phase at a significantly lower OD600 than observed at the
aerobic growth (Fig 8A). Rigorous micro-aerobic conditions were
then promoted at the stationary phase by a decrease in agitation.
Norvaline production was further stimulated by adding glucose to
the culture at regular time intervals (see Materials and Methods).
Cell viability was sampled via the colony forming unit assay 10 and
40 h after promotion of micro-aerobic growth. The strain incapable
of LeuRS editing exhibited a two-fold drop relative to the WT strain
in the number of viable cells after 10 h of micro-aerobic growth,
whereas the difference increased to 87-fold after 40 h (Fig 9B and C).
The 18-fold drop in viability (2.8 × 108 versus 1.6 × 107; Fig 9C)
during prolonged growth under micro-aerobic conditions, which is
observed only with the D345A strain, clearly links LeuRS editing
with E. coli survival under oxygen-limited, norvaline-rich growth
conditions.
Discussion
Here, we find that EcLeuRS discriminates robustly against isoleucine
at the amino acid activation and aminoacylation steps, with specific-
ity of better than 104-fold (Table 1, Fig 2). This is substantially
higher than the minimal discrimination that is generally accepted to
be necessary for sufficient translational fidelity (1 in 3,300, Loftfield
& Vanderjagt, 1972) and thus obviates the need for post-transfer
editing of isoleucine. Our data correct the misconception that isoleu-
cine mimics leucine in the LeuRS synthetic reactions. The essential
difference between this work and previous studies that reported
A B
Figure 7. AMP and Ile-tRNALeu production in parallel reaction assays.
A, B Time-courses following AMP production are illustrated with filled symbols, while time-courses following Ile-tRNALeu production are illustrated with empty
magenta-colored symbols. (A) 250 nM D345A LeuRS. (B) 250 nM WT LeuRS. Because of the low Ile-tRNALeu accumulation by WT LeuRS, the formation rate of
0.0022 s1 (B) should be taken as an approximate value. The rate constants represent the best fit value  s.e.m. of three independent experiments.
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weak isoleucine discrimination by EcLeuRS (Boniecki et al, 2008;
Chen et al, 2000; Lue & Kelley, 2005; Martinis & Fox, 1997) is the
purification step we introduced to eliminate traces of leucine from
isoleucine samples. Remarkably, all tested commercial isoleucine
samples were contaminated by leucine to various extents (0.0019–
0.38%, Supplementary Materials and Methods). Contamination of
isoleucine by leucine, a problem which has not previously been
highlighted, leads to substantial underestimation of LeuRS specific-
ity for isoleucine (Supplementary Table S1). Indeed, production and
utilization of ultra-pure isoleucine (around 0.00035% of leucine)
were necessary for a clear demonstration of the inability of
isoleucine to challenge the accuracy of leucylation. Several lines of
evidence now indicate that the major threat for error-free leucyla-
tion is instead posed by the non-proteinogenic amino acid norvaline
(see below).
Two idiosyncratic features of EcLeuRS discrimination against
isoleucine are: (i) specificity is also exercised at the chemical steps
and (ii) ground state discrimination operates in part via rejection of
the most abundant isoleucine conformer in solution (trans). This
differs from so far described specificity mechanisms in class Ia edit-
ing AARSs (Cvetesic et al, 2012; Dulic et al, 2010; Fersht & Ding-
wall, 1979b). An origin of specificity established at the chemical
A B
C D
E F
Figure 8. Norvaline, isoleucine, and leucine toxicity.
A Growth curves of LeuRS WT (♦) or editing-deficient (D345A LeuRS) (●) E. coli strains in the presence (◊, ○) or absence (♦, ●) of 1.5 mM Nva.
B Concentration-dependent toxicity of norvaline. Errors bars correspond to the s.e.m. from four independent experiments.
C Growth curves of LeuRS WT (♦) or editing-deficient (D345A LeuRS) (●) E. coli strains in the presence (◊, ○) or absence (♦, ●) of 100 mM Ile.
D Concentration-dependent toxicity of isoleucine. Errors bars correspond to the s.e.m. from four independent experiments.
E Growth curves of LeuRS WT (♦) or editing-deficient (D345A LeuRS) (●) E. coli strains in the presence (◊, ○) or absence (♦, ●) of 80 mM Leu.
F Concentration-dependent toxicity of leucine. Errors bars correspond to the s.e.m. from four independent experiments.
The EMBO Journal Vol 33 | No 15 | 2014 ª 2014 The Authors
The EMBO Journal LeuRS editing preserves the canonical genetic code Nevena Cvetesic et al
1648
Published online: June 16, 2014 
steps is not clear yet. It has been recently argued for DNA
polymerases, another family of editing enzymes, that the
non-cognate substrate binding energy may be used to misalign the
catalytic residues (Johnson, 2010). Fluorescence analyses indeed
indicated that T7 DNA-polymerase bound to near-cognate nucleo-
tide adopts a mismatch conformation that impedes catalysis and
promotes substrate release (Tsai & Johnson, 2006). The crystal
structure of the LeuRS:tRNALeu complex bound to an Ile-AMP
analogue, however, does not provide evidence for a distinct, long-
lived non-cognate conformation that could be responsible for the
slow chemical step, although this possibility cannot be fully
excluded. Thus, it seems plausible to assume that no active site
determinants participate in unproductive Ile-AMP binding. Instead,
assembly of the catalytic residues for the isoleucyl transfer step
likely occurs through a slower isoleucine-dependent conformational
change, which may limit the measured ktrans. One may also argue
that isoleucine is specifically distinguished at the transition state.
Interestingly, a-aminobutyrate, which lacks side chain binding
capacity, is activated and transferred at rates comparable to the
cognate reaction. This may indicate that the amino acid side chain
does not significantly contribute to transition state stabilization in
LeuRS. However, steric constraints imposed by the different branch-
ing of the isoleucine side chain may influence the functional
contacts at the transition states.
A lack of sufficient binding energy for the b-branched isoleucine
side chain in combination with preferential binding of the less abun-
dant isoleucine conformation (gauche –) results in very weak affin-
ity for isoleucine (Table 1, Figs 2 and 5). The established low
affinity, however, might not suffice to provide the high specificity
observed against isoleucine (~31,000). Instead, a significant portion
of the selectivity also arises at the chemistry steps. Our data open a
new perspective about AARS selectivity mechanisms, showing that
specificity against non-cognate amino acids may arise in part from
preferential binding of higher-energy conformers. This complements
the double-sieve model (Fersht, 1998), which proposes that a
synthetic site acts as a coarse-sieve that rejects larger amino acids
solely by steric exclusion. It remains to be seen whether this mecha-
nism is unique for isoleucine rejection by EcLeuRS or is widespread
A
C
B
Figure 9. Cell viability under micro-aerobic conditions.
A Growth curves of LeuRS WT (●) or editing-deficient (D345A LeuRS) (○) E. coli strains. The black arrow indicates the start of the glucose feed and promotion of the
micro-aerobic conditions by reduced agitation. The purple and red arrows indicate the time-points when the cultures were sampled for the CFU assay.
B Representative plate dilutions of both WT and D345A strains from the CFU assay performed after 50 h of growth under micro-aerobic conditions.
C Cell viability of WT and D345A strains grown in aerobic conditions (blue column chart, 20 h of growth) and micro-aerobic conditions (purple column chart, 20 h of
growth, red column chart, 50 h of growth). Note that labels of the y-axis for each of the column charts are in different orders of magnitude. Errors correspond to the
s.e.m. from four independent experiments.
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among different LeuRSs or even other AARSs. Indeed, structural
and kinetic analyses demonstrate that Met40 is a key determinant of
EcLeuRS specificity against isoleucine (Table 1, Fig 4C). However,
whereas Met40 is conserved in bacteria, it is not conserved among
LeuRSs from other domains of life (Supplementary Fig S5). Some
archaeal LeuRSs have alanine instead of methionine, while the cyto-
solic eukaryotic LeuRS mostly have proline. We produced M40A
LeuRS and tested its activation of isoleucine. Minimal effects on
the Km and kcat values were observed (Km = 20  4 mM,
kcat = 1.05  0.08 s1), consistent with a model whereby the
b-carbon atom of Met40 plays the most prominent role in steric
exclusion of the trans isoleucine. Additional support for the model
comes from the observation that homologous positions in IleRSs are
occupied by the absolutely conserved glycine, presumably to
preclude steric clash with the isoleucine in trans conformation
(Supplementary Fig S5).
Specificity in non-editing AARSs generally originates from the
lack of synthetic site binding determinants for the non-cognate
amino acids, providing insufficient binding energy for substantial
ground and transition state stabilization (Perona & Hadd, 2012).
Alternatively, the synthetic site may drive unproductive binding of
the non-cognate amino acid (Bullock et al, 2003) or may impose
steric hindrance to ensure selectivity (Arnez et al, 1999). Conse-
quently, a prominent increase in Km and decrease in kcat jointly
establish 105–107-fold specificity (Fersht & Dingwall, 1979a; Uter
et al, 2005). If an AARS is unable to discriminate with at least 10-3
frequency against non-cognate amino acid in the synthetic reaction,
editing becomes critical. This generally holds for AARSs which are
incapable of exerting specificity at the catalytic steps (Fersht, 1977;
Fersht & Kaethner, 1976; Beebe et al, 2003; Guo et al, 2009; Ling
et al, 2012; Sankaranarayanan et al, 2000; Yadavalli & Ibba, 2013).
Intriguingly, LeuRS resembles editing tRNA synthetases in its speci-
ficity against norvaline, while it discriminates against isoleucine in a
manner more closely related to non-editing AARSs. Consistent with
this, in vivo studies show that loss of LeuRS post-transfer editing
had dramatic consequences on cell growth only in the presence of
norvaline. The strain lacking LeuRS post-transfer editing tolerates
isoleucine at a concentration substantially higher than its physiolog-
ical concentration in E. coli (20 mM (Fig 8C and D) versus 0.3 mM
(Bennett et al, 2009)), thus underpinning the irrelevance of isoleu-
cine editing. This finding has important implications to the develop-
ment of antimicrobial agents. Recently, boron-based benzoxaborole
compounds have been developed that inhibit fungal (Rock et al,
2007) and bacterial (Hernandez et al, 2013) LeuRSs, by covalently
trapping enzyme-bound tRNALeu in the CP1 editing site. However,
in clinical trials, benzoxaborole-resistant bacterial mutants emerged,
showing that the cell can establish antibiotic resistance at the
expense of LeuRS post-transfer editing (Hernandez et al, 2013). This
is consistent with the reported irrelevance of isoleucine editing
in vivo. To decrease the frequency with which resistant mutants
emerge, norvaline-rich conditions could be artificially induced to
promote growth conditions where LeuRS post-transfer editing is
essential for cell survival (Fig 8A and B).
The combination of both high amino acid specificity and an
active post-transfer editing mechanism against non-cognate tyrosine
and alanine was previously recognized in E. coli PheRS (Reynolds
et al, 2010) and ProRS (Beuning & Musier-Forsyth, 2000), respec-
tively. Therefore, the appearance of dual checkpoints in at least
PheRS, LeuRS, and ProRS indicates that E. coli relies on several
quality control mechanisms to ensure adaptability under highly
different physiological conditions. It has recently been suggested
that requirements for quality control mechanisms may be species-
specific and condition-dependent (Beuning & Musier-Forsyth, 2001;
Reynolds et al, 2010; SternJohn et al, 2007). In accordance, we
show here that AARS editing may operate to preserve canonical
translation only under particular conditions of growth. Under
normal aerobic conditions, E. coli easily tolerates editing-deficient
LeuRS, implying that LeuRS post-transfer editing is irrelevant for
normal growth as already demonstrated for E. coli PheRS editing
(Reynolds et al, 2010). Conversely, mistranslation of leucine codons
under micro-aerobic conditions significantly decreases cell viability
(Fig 9B and C). Its toxicity is likely a consequence of misfolding and
aggregation (Drummond & Wilke, 2009) of the norvaline enriched
proteins (Weber & Miller, 1981). Indeed, growth in a norvaline-
rich environment is rescued by the powerful LeuRS post-transfer
editing activity which eliminates norvaline from the genetic code
(Fig 8A). This capacity provides E. coli with flexibility to encounter
both oxygen-rich and oxygen-deprived ecological niches. Our
results show that AARS-mediated translational quality control is
interconnected with the E. coli adaptive response mechanisms to
provide survival under quickly changing oxygen environments.
Materials and Methods
EcLeuRS kinetic assays
EcLeuRS enzymes and tRNALeuUAA were produced and purified by
standard procedures (Cvetesic et al, 2012). The enzymes used in
single-turnover assays were subjected to a second purification step
designed to remove Leu-AMP bound in the enzyme’s active site, as
described (Cvetesic et al, 2012).
[32P]-tRNALeu used in kinetic assays was prepared using tRNA
nucleotidyltransferase (Wolfson & Uhlenbeck, 2002). All rate
constants obtained through [32P]-tRNALeu measurement were
corrected by the factor that reflects the proportion of functional
[32P]-tRNALeu (Cvetesic et al, 2012).
All assays were performed at 37 °C in the standard LeuRS reac-
tion buffer that contains 100 mM Hepes-KOH, pH 7.5, 10 mM
MgCl2, 150 mM KCl, and 5 mM DTT with appropriate amounts of
enzyme, amino acid, or ATP. Steady-state reactions were supple-
mented with 100 lg/ml BSA for enzyme stabilization. All experi-
ments were routinely repeated at least three times.
ATP-PPi exchange was performed using 4 mM ATP and 1 mM
[32P]-PPi (Cvetesic et al, 2012). The parameters for isoleucine acti-
vation were determined using the ultra-pure sample (around
0.00035% leucine).
Aminoacyl-adenylate synthesis assay was performed as
described (Cvetesic et al, 2012). The reactions included 0.5 mM
[a-32P]-ATP (0.01–0.1 mCi/ml), 0.004 U/ll inorganic pyrophospha-
tase (IPPase), with or without 20 lM active tRNALeu.
The Ile-AMP stability test was performed with ultra-pure isoleu-
cine, as previously published (Cvetesic et al, 2012).
[32P]-AMP and Ile-[32P]-tRNALeu formations were followed in
parallel steady-state assays as described (Cvetesic et al, 2012).
Briefly, the reactions were supplemented with 0.004 U/ll IPPase,
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using either 0.25 lM WT or D345A LeuRS in the presence of
200 lM ATP, 20 lM active tRNALeu, and 50 mM Ile (ultra-pure).
The transfer step was measured using D345A LeuRS:Ile-AMP or
D345A LeuRS:Aba-AMP complexes pre-formed by incubation of
60 lM D345A LeuRS with 8 mM ATP, 0.008 U/ll IPPase, and
10 mM Ile or 100 mM Aba, respectively, for 15 min at 37°C. Equal
volumes of 60 lM LeuRS:AA-AMP were mixed with 12 lM active
[32P]-tRNALeu in the KinTek RQF-3 instrument, as described (Cvete-
sic et al, 2012; Dulic et al, 2010). Several controls were performed
to confirm that the measured rate constant represents the true trans-
fer rate constant and is not limited by slow amino acid activation.
Both, the incubation time for in situ formation of LeuRS:AA-AMP
and the concentration of Ile or Aba were varied, and no influence
on the observed rate constant was revealed. Furthermore, transfer
of isoleucine was measured using the isolated D345A LeuRS:Ile-
AMP non-covalent complex. The complex was formed as described
above, cooled by placing on ice, and isolated by size-exclusion chro-
matography on Sephadex G-25. Due to its instability, the isolated
complex was constantly kept at low temperature, the syringe used
for loading the complex was cooled in ice prior to use, and a
construction that enables ice cooling of the syringe mounted on the
sample port was used throughout data collection. The complex was
preheated to 37°C by 1–2 min incubation in the RQF-3 instrument,
prior to mixing with tRNA.
Single-turnover isoleucylation was performed using the KinTek
RQF-3 instrument by mixing equal volumes of 60 lM D345A
LeuRS, 12 lM [32P]-tRNALeu, 8 mM ATP, and 0.008 U/ll IPPase
incubated in one syringe, with various concentrations of isoleucine
incubated in the second syringe. Single-turnover leucylations were
performed in the same manner, albeit 20 lM D345A LeuRS and 2
lM tRNALeu were used. Time-courses were fit to a first-order
exponential equation, and the extracted rate constants (kobs) were
fit to the hyperbolic binding equation (kobs = S0 × kchem/S0 + Kd).
Various mixing modes showed no influence on the extracted rate
constants.
Construction of the editing-deficient D345A-LeuRS E. coli strain
E. coli strain MG1655 was obtained from the E. coli Genetic Stock
Center and used as the parent strain to create the editing-
deficient D345A LeuRS strain. Replacement of the chromosomal WT
leuS with the gene for D345A LeuRS was performed using the pKOV
vector, according to the published procedures (Link et al, 1997).
The positives were selected by their sensitivity to norvaline and
confirmed by sequencing (for details see Supplementary Materials
and Methods).
Amino acid toxicity experiments
The WT and editing-deficient D345A-LeuRS strains were inoculated
into LB media from the colonies grown on LB plates and were
grown overnight at 37°C, 200 rpm. The cultures were diluted 1:100
into minimal M9 medium with 0.2% glucose and the various
concentrations of either norvaline, isoleucine, or leucine. The
cultures were grown at 37°C, 200 rpm, and the growth curves were
generated by following OD600. For both, the WT and deacylation-
deficient strains, two independently obtained strains were used as
biological replicates. To obtain growth rates, the growth curves
were fitted to the logistic model y = A/(1 + e(4 × l/A × (kt) + 2)),
where A represents the maximum cell growth, k represents the
length of the lag phase, and l represents the growth rate. All experi-
ments were performed in duplicates; the obtained growth rates were
averaged, plotted against amino acid concentration, and fitted to the
sigmoidal dose-response curve to acquire IC50.
Cell viability under micro-aerobic conditions
The WT and editing-deficient D345A-LeuRS MG1655 strains were
inoculated into LB media from single colonies and grown overnight
in aerobic conditions at 37°C, 200 rpm, until saturation was
reached. Two independently obtained WT and D345A strains were
used as biological replicates. The starter cultures were diluted 1:100
into minimal M9 medium supplemented with 2% glucose. To
achieve micro-aerobic growth conditions, the M9 medium was
degassed by sonication prior to inoculation, and the experiment was
performed in 50 ml of media incubated in 50 ml conical tubes.
Growth was followed at OD600, and the cultures were agitated at
150 rpm at 37°C, until they reached a stationary growth phase.
Agitation was then lowered to 100 rpm to reduce the oxygen trans-
fer, and the cultures were supplemented with glucose at regular
time intervals (approximately every 2 h during the first 12 h, and
then after 14 h, 1 ml of 50% glucose was added). The colony form-
ing unit assay was performed after 20 and 50 h of growth. Decimal
and serial dilutions were made in phosphate buffered saline, and
100 ll of each dilution was evenly spread on LB plates and incu-
bated overnight. Colony count was performed only with plate dilu-
tions that had more than 30 and less than 300 colonies. CFU/ml for
WT and D345A strain was expressed as an average of two biological
replicas, each with at least two dilution replicas.
Control experiment was performed under aerobic conditions.
10 ml of M9 medium was inoculated 1:100 with starter cultures
(WT or D345A strain) and incubated in 50-ml conical tubes. Growth
was followed at OD600, and the cultures were agitated at 37°C,
200 rpm to maximize oxygen transfer. CFU assay was performed as
described above.
Crystallization
Production and purification of LeuRS and tRNALeu in vitro transcript
for crystallization were followed as described (Palencia et al, 2012).
Crystallization was performed at 20°C by the hanging drop vapor
diffusion method. A solution containing 51 lM LeuRS, 58 lM
tRNALeu, and 2.5 mM Ile-AMS (purchased from RNA-TEC, Leuven,
Belgium) was prepared prior to the crystallization experiments.
Crystals were obtained by mixing 2 ll of this solution with 2 ll of
the reservoir solution containing 0.1 M Bis-Tris (pH 5.5), 23–25%
PEG 3350, and 0–200 mM ammonium acetate. The crystals were
frozen in liquid nitrogen prior to X-ray exposure without added
cryoprotectant. Structure determination and refinement were
performed by standard procedures (for details see Supplementary
Materials and Methods).
Isothermal titration calorimetry (ITC) measurements
ITC measurements were taken at 25°C using an ITC200 Micro-calo-
rimeter (MicroCal Inc). Experiments included 26 stepwise, automated
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injections (Vinjection = 1.5 ll) of amino acid (2–10 mM), or AA-AMP
analogue (0.3–0.6 mM) solutions into the sample cell containing the
protein (20–70 lM) in 25 mM Tris–HCl pH 7.4, 150 mM NaCl, 5 mM
MgCl2, and 5 mM 2-b-mercaptoethanol buffer. Amino acids
(purchased from Sigma) and AA-AMP analogues (acquired from
RNA-TEC) were dissolved in the same buffer as the protein, and
when necessary, the pH was readjusted. For the experiments with
isoleucine, ultra-pure isoleucine sample was used (around 0.00035%
of leucine contamination). Control experiments were performed
under identical conditions by injecting the ligands into the buffer to
correct the dilution heats into the buffer. Binding isotherms were fit
by nonlinear regression using Origin Software version 7.0 (MicroCal
Inc). The initial data point was routinely not used in the fitting. The
data were fit to a one-site binding model using the software provided
by MicroCal (Turnbull & Daranas, 2003; Wiseman et al, 1989).
Accession codes
Protein data bank: Coordinates have been deposited with accession
code 4cqn.
Supplementary information for this article is available online:
http://emboj.embopress.org
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